FDA Seeks Fines From Advanced Bionics And Execs For Not Filing Supplement
This article was originally published in The Gray Sheet
Executive Summary
FDA is pursuing Advanced Bionics and its two co-CEOs for $1.1 million each in fines, alleging that the company did not file a PMA supplement for adding a vendor for a component of its cochlear implant
You may also be interested in...
Advanced Bionics Requests Extra Time To Answer Amended FDA Complaint
Cochlear implant maker Advanced Bionics and CEO Jeff Greiner requested extra time April 15 to respond to FDA's amended administrative complaint against the firm, which adds three quality systems violation allegations to the original suit
Advanced Bionics Requests Extra Time To Answer Amended FDA Complaint
Cochlear implant maker Advanced Bionics and CEO Jeff Greiner requested extra time April 15 to respond to FDA's amended administrative complaint against the firm, which adds three quality systems violation allegations to the original suit
FDA May Wield Prosecutorial Authority More Frequently
Device companies can expect more active legal prosecution by FDA for off-label and product safety issues as the agency improves its ability to track products on the market and as the activity of industry whistleblowers grows, according to government and agency staffers